BIOJECT MEDICAL TECHNOLOGIES INC 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jun 11, 2010
Insider Transaction Report
Form 4
FARRELL CHRISTINE
VP of Finance
Transactions
- Award
Option (Right to buy)
2010-06-10$0.15/sh+240,000$36,000→ 509,171 totalExercise: $0.15Exp: 2017-06-09→ BJCT Common Stock (240,000 underlying)
Holdings
- 254,024
Beneficial Holdings - BJCT
- 85,741(indirect: By 401(k))
Beneficial Holdings - BJCT
Footnotes (2)
- [F1]Vesting schedule: 25% on 6/10/11, 25% on 6/10/12, 25% on 6/10/13 and 25% on 6/10/14
- [F2]Holdings: Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Restricted Stock Units 64,000, Option (Right-to-buy) 434,071.